RecruitingNot ApplicableNCT07273526

Adrenaline V/s Dopamine in Fuid Refractory Septic Shock

Comparison of the Efficacy of Renaline and Dopamine in the Treatment of Fluid Refractory Septic Shock in Children


Sponsor

Laiba Qamar

Enrollment

90 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study compares the efficacy of two drugs i.e Adrenaline and dopamine in fluid refractory type of septic shock which is a dreadful medical condition especially in children. The efficacy will be checked based on heart rate , GCS, capillary refill time , palpable pripheral pulse , urine output and systolic blood pressure.


Eligibility

Min Age: 1 MonthMax Age: 12 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Adrenaline and a drug called Dopamine for people with fluid refractory septic shock and septic shock. The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Month to 12 Months.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAdrenaline

The adrenaline will be given as a vasoconstrictor in the dose of 0.1-0.3ug/kg/min to the patients in group A when diagnosed with fluid refractory septic shock

DRUGDopamine

The drug dopamine will be adminitered in dose of 10-20ug/kg/min to the patients of group B when diagnosed with fluid refractory septic shock.


Locations(1)

The Children Hospital and The Institute of Child Health Faisalabad

Faisalābad, Punjab Province, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07273526


Related Trials